In a related commentary, Robert Lindsay, M.B., Ch.B., Ph.D., of Helen Hayes Hospital, West Haverstraw, N.Y., writes: «In this issue of JAMA Internal Medicine, Greenspan and colleague present intriguing data
on zoledronic acid, one of the most potent drugs in the bisphosphonate family — if not the most potent — approved for treatment of osteoporosis.»